Greenwich LifeSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 14, 2022 at 04:19 pm EST
Greenwich LifeSciences, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net loss was USD 2.32 million compared to USD 0.863118 million a year ago. Basic loss per share from continuing operations was USD 0.18 compared to USD 0.07 a year ago.
For the nine months, net loss was USD 5.03 million compared to USD 2.21 million a year ago. Basic loss per share from continuing operations was USD 0.39 compared to USD 0.17 a year ago.